Compound used as RET kinase inhibitor and application thereof

The present invention relates to the technical field of medicines. Specifically disclosed is a compound as represented by formula I', or a pharmaceutically acceptable salt, stereoisomer, solvate, or prodrug thereof, symbols therein being as defined in the claims. The compound of the present inv...

Full description

Saved in:
Bibliographic Details
Main Authors NIU, Chengshan, LIANG, Apeng, WU, Yusheng, LI, Jun, ZHENG, Maolin
Format Patent
LanguageEnglish
Published 02.02.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the technical field of medicines. Specifically disclosed is a compound as represented by formula I', or a pharmaceutically acceptable salt, stereoisomer, solvate, or prodrug thereof, symbols therein being as defined in the claims. The compound of the present invention may be used as a drug for regulating RET kinase activity or treating RET-related diseases, and has good pharmacokinetic properties.
Bibliography:Application Number: AU20210276206